This article provides a comprehensive analysis of contemporary combination therapy strategies involving immune checkpoint inhibitors (ICIs), tailored for researchers and drug development professionals.
This comprehensive guide explores the critical role of ISO standards in establishing robust, reliable, and globally harmonized organoid biobanks.
This article provides a detailed analysis of the International Society of Liquid Biopsy (ISLB) standards for circulating tumor DNA (ctDNA) testing.
This comprehensive guide provides researchers and drug development professionals with an up-to-date, detailed protocol for immunohistochemical (IHC) detection of key non-small cell lung cancer (NSCLC) biomarkers: ALK, ROS1, and EGFR.
This article provides a comprehensive analysis of IDO (Indoleamine 2,3-dioxygenase) inhibition as a strategic approach to combat resistance to immune checkpoint blockade (ICB) therapies like anti-PD-1/PD-L1.
This article provides a comprehensive, evidence-based review of corticosteroid management protocols for immune checkpoint inhibitor (ICI)-induced hepatotoxicity, tailored for researchers and drug development professionals.
This article provides a comprehensive analysis of Hypoxia-Inducible Factor-1α (HIF-1α) as a master regulator of immune cell adaptation and dysfunction within the hypoxic Tumor Microenvironment (TME).
This article provides a comprehensive mechanistic and applied analysis of how immune checkpoint inhibitors (ICIs) overcome tumor-induced T-cell suppression to reactivate anti-cancer immunity.
This comprehensive review provides researchers, scientists, and drug development professionals with a critical head-to-head comparison of leading Cancer Stem Cell (CSC) isolation techniques.
This comprehensive review synthesizes current research on the gut microbiome's critical role in modulating patient response to immune checkpoint inhibitors (ICIs).